. Author manuscript; available in PMC: 2011 Mar 26.

Published in final edited form as: Am J Physiol Regul Integr Comp Physiol. 2007 Nov 14;294(2):R402–R410. doi: 10.1152/ajpregu.00650.2007

Table 4.

LPS-specific immunoglobulins in SBS patients and control subjects

	Baseline	Week 4	Week 8	Week 12	Week 16	Week 20	Week 24
SBS IgM	1.26±0.06	1.35±0.07^†	1.37±0.06^†^‡	1.23±0.08	1.31±0.08	1.24±0.08	1.32±0.06
Control IgM	1.21±0.08
SBS IgA	1.19±0.15^*^§	1.23±0.15^§	1.29±0.13^§	1.16±0.13	1.29±0.12	1.11±0.11	1.06±0.09
Control IgA	0.74±0.08
SBS IgG	0.85±0.10	0.91±0.12^‡^§	0.92±0.11^‡^§	0.81±0.11^§	0.90±0.11	0.77±0.10	0.73±0.1.0
Control IgG	0.67±0.08

Data are means ± SE, expressed as optical density readings.

P ≤ 0.001, SBS (n = 23) vs. control subjects (n = 48).

^†

P < 0.05 vs. week 12.

^‡

P < 0.05 vs. week 20.

^§

P < 0.05 vs. week 24.